Concepedia

Nataliya Razumilava

NR

Statistics

Publications

16

Citations

1.6K

H-Index

13

Active since

2011

Affiliations

University of Michigan(Current)

Mayo Clinic in Arizona

Virginia Commonwealth University

University of California, San Francisco

Nataliya Razumilava is an author at University of Michigan specializing in oncology, medicine, and biliary tract cancer.

Publications per year

2011–2022

16

Publications

16

Cholangiocarcinomas can originate from hepatocytes in mice

Biao Fan, Yann Malato, Diego F. Calvisi et al. · Journal of Clinical Investigation · 2012 · 550 citations

Medicine, Cancer Biology, Cell Biology +17

Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation

Jun Li, Nataliya Razumilava, Gregory J. Gores et al. · Journal of Clinical Investigation · 2014 · 201 citations · Full text

Life Sciences, Immunology, Pathobiology +17

miR-25 Targets TNF-Related Apoptosis Inducing Ligand (TRAIL) Death Receptor-4 and Promotes Apoptosis Resistance in Cholangiocarcinoma

Nataliya Razumilava, Steve F. Bronk, Rory L. Smoot et al. · Hepatology · 2011 · 191 citations · Full text

Medicine, Cancer Biology, Oncology +17

IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism

Daisaku Yamada, Sumera I. Ilyas, Nataliya Razumilava et al. · Hepatology · 2015 · 139 citations · Full text

Medicine, Oncology, Pathobiology +14

Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation

Elise S. Hibdon, Nataliya Razumilava, Theresa M. Keeley et al. · Neoplasia · 2019 · 87 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 16